$0.66 -0.03 (-4.35%)
11/27/2009 1:00 PM

MiddleBrook Pharmaceuticals, Inc. (MBRK)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on developing and commercializing anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease.

Featured Broker Partners